Ipsen Pharma released a statement of transactions in own shares from September 8th to September 12th, 2025. The report includes the name of the issue, identity code of the issuer, day of the transaction, identity code of the financial instrument, total daily volume in number of shares, daily weighted average purchase price of the shares, and market (MIC Code). The data shows the buy-back activity of Ipsen Pharma in various markets over the specified period. For more details, refer to the official statement by Ipsen Pharma.

Read more at GlobeNewswire: IPSEN – Buy-back programme – Art 5 of MAR – Week 37